“…[223][224][225][226][227] The latter problem is usually solved (Scheme 27) by performing the macrolactonization on the ynoic seco-acid and then reducing the triple bond, as illustrated in the synthesis of laulimalide. 227 To date, the Yamaguchi protocol and variations have been used in more than 200 synthetic applications, including eightmembered lactones; 228,229 nine-membered halicholactone 230,231 and a nine-membered intermediate to laurencin; 232 10-membered didemninlactone, 233 decarestricine, 234 mueggelone, 235,236 hebarumin, 237 and ascidiatrienolide; 238 cyclodepsipeptides such as geodiamolide, 342 globomycin, 343 and stevastelin; 344 nonactin [345][346][347][348] aspicilin; 293,349-352 44-membered swhinholide; 72,[353][354][355] acutiphycin; 356,357 scytophycin; 69,358,359 aplyronine A; 67,360-362 aplyolide; 363,364 hygrolidin; 198 nargenicin and dinemycin A precursors; 365,366 bafilomycin, where the Mukaiyama, Keck, and Palomo protocols failed; 367 apoptolidinone; 61,62,368,369 conglobatin; 209 and macrocyclic glycolipids, 12 such as tric...…”